Skip to content

Post-discharge Nutrition and Resistance Training in Surgical Patients

Malnutrition in Surgical Patients in the Faroe Islands: Post-discharge Nutrition and Resistance Training

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03327935
Acronym
MaSu
Enrollment
45
Registered
2017-11-01
Start date
2018-05-01
Completion date
2020-04-01
Last updated
2020-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malnutrition, Surgery

Brief summary

Randomized intervention by nutritional supplements and training in postoperative patients after discharge

Detailed description

Surgery combined with malnutrition is associated with loss of muscle mass and leads to serious consequences for the surgical patient. A majority of surgical patients continue to lose weight after discharge. Nutritional risk screening has not been fully implemented at Landssjúkrahúsið - the National Hospital of the Faroe Islands and therefore the prevalence of patients at nutritional risk is unknown. The aim of this study is to examine whether an intervention with independent nutritional supplements or an intervention combining nutritional supplements and resistance training is more effective in preventing loss of muscle mass than standard care in surgical patients following discharge. Secondary outcomes are changes in body weight, quality of life, muscle strength and activities of daily living. Furthermore, we want to screen hospitalized surgical patients for nutritional risk in order to get an estimate of the prevalence of nutritional risk.

Interventions

DIETARY_SUPPLEMENTNutrition

150 Faroese surgical patients randomized to one of the following three arms 1) oral nutritional supplements and advice, 2) oral nutritional supplements and training exercise and 3) Standard hospital procedure. Primary outcome is loss of lean body mass

Sponsors

Health Insurance Fund of Research Council Faroe Islands
CollaboratorUNKNOWN
National Hospital of the Faroe Islands
CollaboratorOTHER_GOV
Société des Produits Nestlé (SPN)
CollaboratorINDUSTRY
University of Copenhagen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

Baseline data are collected prior to the randomization and thus are masked. But during and after the intervention both participants and investigators are unblinded.

Intervention model description

3 groups of 50 patients each by randomization

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Admitted to the surgical departments at Landssjúkrahúsið - National Hospital of Faroe Islands * Aged 18 years or above * One or more of the following surgical procedures: knee alloplasty, hip alloplasty, collum femoris fracture, back fracture, abdominal surgery, mamma surgery and other comprehensive surgery * At nutritional risk according to screening

Exclusion criteria

* Minimally invasive surgery/Laparoscopic surgery * Severely reduced kidney function (p-creatinin\>250 mikromol/l) or dialysis * Terminal illness * Inability to cooperate in tests or exercises due to cognitive function or dementia * Admitted to intensive care unit * Inability to speak or understand Faroese, Danish or English * Consent according to national regulations not obtainable

Design outcomes

Primary

MeasureTime frameDescription
Loss of lean body mass8 weeksNon-bone lean mass measured by dual energy x-ray absorptiometry (DXA) whole-body scans

Countries

Faroe Islands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026